COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study

被引:40
作者
Dziedzic, Arkadiusz [1 ]
Issa, Julien [2 ,3 ]
Hussain, Salman [4 ]
Tanasiewicz, Marta [1 ]
Wojtyczka, Robert [5 ]
Kubina, Robert [6 ]
Konwinska, Marta Dyszkiewicz [2 ,7 ]
Riad, Abanoub [8 ]
机构
[1] Med Univ Silesiaia, Dept Conservat Dent Endodont, Katowice, Poland
[2] Poznan Univ Med Sci, Dept Diagnost, Poznan, Poland
[3] Poznan Univ Med Sci, Doctoral Sch, Poznan, Poland
[4] Masaryk Univ, Czech Natl Ctr Evidence Based Healthcare & Knowle, Cochrane Czech Republ, Czech EBHC JBI Ctr Excellence,Masaryk Univ GRADE, Brno, Czech Republic
[5] Med Univ Silesiaia, Dept Microbiol & Virol, Sosnowiec, Poland
[6] Med Univ Silesiaia, Dept Pathol, Sosnowiec, Poland
[7] Poznan Univ Med Sci, Dept Anat, Poznan, Poland
[8] Masaryk Univ, Fac Med, Dept Publ Hlth, Brno, Czech Republic
关键词
cross-sectional studies; COVID-19; vaccines; decision making; healthcare professionals; vaccination hesitancy; Poland;
D O I
10.3389/fpubh.2022.938067
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.
引用
收藏
页数:14
相关论文
共 59 条
[1]   Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study [J].
Al-Qerem, Walid ;
Al Bawab, Abdel Qader ;
Hammad, Alaa ;
Ling, Jonathan ;
Alasmari, Fawaz .
VACCINES, 2022, 10 (03)
[2]  
Aleem A, EMERGING VARIANTS SA
[3]   World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects [J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (20) :2191-2194
[4]  
[Anonymous], 2022, STAY DAT YOUR COVID
[5]  
[Anonymous], 2021, ED 1
[6]   Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees [J].
Attia, Sameh ;
Mausbach, Katharina ;
Klugar, Miloslav ;
Howaldt, Hans-Peter ;
Riad, Abanoub .
FRONTIERS IN PUBLIC HEALTH, 2022, 10
[7]   Attitudes of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland [J].
Babicki, Mateusz ;
Mastalerz-Migas, Agnieszka .
VACCINES, 2022, 10 (01)
[8]   Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel [J].
Bar-On, Yinon M. ;
Goldberg, Yair ;
Mandel, Micha ;
Bodenheimer, Omri ;
Freedman, Laurence ;
Kalkstein, Nir ;
Mizrahi, Barak ;
Alroy-Preis, Sharon ;
Ash, Nachman ;
Milo, Ron ;
Huppert, Amit .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15) :1393-1400
[9]  
Centers for Disease Control Prevention (CDC), POP SURV DESCR STUD
[10]   Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar [J].
Chemaitelly, Hiam ;
Tang, Patrick ;
Hasan, Mohammad R. ;
AlMukdad, Sawsan ;
Yassine, Hadi M. ;
Benslimane, Fatiha M. ;
Al Khatib, Hebah A. ;
Coyle, Peter ;
Ayoub, Houssein H. ;
Al Kanaani, Zaina ;
Al Kuwari, Einas ;
Jeremijenko, Andrew ;
Kaleeckal, Anvar H. ;
Latif, Ali N. ;
Shaik, Riyazuddin M. ;
Rahim, Hanan F. Abdul ;
Nasrallah, Gheyath K. ;
Al Kuwari, Mohamed G. ;
Al Romaihi, Hamad E. ;
Butt, Adeel A. ;
Al-Thani, Mohamed H. ;
Al Khal, Abdullatif ;
Bertollini, Roberto ;
Abu-Raddad, Laith J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24) :E83-E83